Citations 1
Pembrolizumab in Combination with Epigenetic Therapy Is Safe and Active in Heavily Treated Patients with Peripheral T-Cell Lymphoma (PTCL) and Cutaneous T-Cell Lymphoma (CTCL): Preliminary Results from the Embolden Trial
Lister, John , Jain, Salvia , Battaglia, Tammy, Ayers, Emily C. , Portell, Craig A. , Williams, Michael E. , Pal, Ipsita , O’Connor, Owen A. , Manavalan, John S., Marchi, Enrica , Portell, Craig A , Roberts, Nathan, Bennani, N. Nora , Batchala, Prem Pradeep
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9425-9426
